Neuroleptic malignant syndrome and serotonin syndrome - severe adverse reactions with psychotropic medications
Neuroleptic malignant syndrome and serotonin syndrome are two conditions that can occur with psychotropic medications. Although both states are associated with psychiatric care they can also occur in somatic settings. The clinical pictures are complex with many different symptoms of varying severity. Both diagnoses are therefore easy to miss. Opinions remain divided on how to treat both states pharmacologically. The aim of this article is to increase the understanding and awareness of these potentially life-threatening conditions, which arise from treatment with dopaminergic or serotonergic substances.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:117 |
|---|---|
| Enthalten in: |
Lakartidningen - 117(2020) vom: 15. Sept. |
| Sprache: |
Schwedisch |
|---|
| Weiterer Titel: |
Malignt neuroleptikasyndrom och serotonergt syndrom |
|---|
| Beteiligte Personen: |
Truedson, Petra [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 23.10.2020 Date Revised 23.10.2020 published: Electronic Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM31512430X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM31512430X | ||
| 003 | DE-627 | ||
| 005 | 20231225154230.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||swe c | ||
| 028 | 5 | 2 | |a pubmed24n1050.xml |
| 035 | |a (DE-627)NLM31512430X | ||
| 035 | |a (NLM)32940904 | ||
| 035 | |a (PII)F3LI | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a swe | ||
| 100 | 1 | |a Truedson, Petra |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neuroleptic malignant syndrome and serotonin syndrome - severe adverse reactions with psychotropic medications |
| 246 | 3 | 3 | |a Malignt neuroleptikasyndrom och serotonergt syndrom |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.10.2020 | ||
| 500 | |a Date Revised 23.10.2020 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Neuroleptic malignant syndrome and serotonin syndrome are two conditions that can occur with psychotropic medications. Although both states are associated with psychiatric care they can also occur in somatic settings. The clinical pictures are complex with many different symptoms of varying severity. Both diagnoses are therefore easy to miss. Opinions remain divided on how to treat both states pharmacologically. The aim of this article is to increase the understanding and awareness of these potentially life-threatening conditions, which arise from treatment with dopaminergic or serotonergic substances | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Psychotropic Drugs |2 NLM | |
| 700 | 1 | |a Ott, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Bernberg, Evelina |e verfasserin |4 aut | |
| 700 | 1 | |a Werneke, Ursula |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lakartidningen |d 1965 |g 117(2020) vom: 15. Sept. |w (DE-627)NLM000007544 |x 1652-7518 |7 nnns |
| 773 | 1 | 8 | |g volume:117 |g year:2020 |g day:15 |g month:09 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 117 |j 2020 |b 15 |c 09 | ||